(02-06-2019, 09:16 AM)mikesez Wrote:

(02-05-2019, 10:51 PM)flsprtsgod Wrote: [quote pid='1192226' dateline='1549417433']
The point is that the price should be going down as the technology gets older and more of the initial investment and development is paid off.
But that's not how it actually works, because these firms don't actually compete with each other, and we can't actually walk away from them.

You can still buy the original for $20 a vile at Walmart. You dont need the newest label, it's just a consumerist desire.

Are you saying the humalog insulin is available for $20 per vial or that the older beef or pork insulin is available for that price?

---

(02-06-2019, 12:08 AM)jj82284 Wrote: Yes Mike, a decade of regulatory compliance causes a shortage of producers and thus lack of true competition.

But who are the producers?
The insurance companies, the hospitals, or the doctors?
[/quote]

Wait, are you saying you pay more for newer technology like that only happens in pharma?

---

(02-06-2019, 01:34 PM)wrong_box Wrote:

(02-05-2019, 06:11 PM)flsprtsgod Wrote: Ummmm, do any of you guys know how much it costs to bring a drug to market? It's more than a few bucks a dose.

To get it on to the market takes time and money. Once on the market all that's left is producing and shipping the product. All the research and development costs have been made,all regulatory obligations satisfied and all that's left is sales

Oh, so you dont then, your argument makes more sense now.

---

(02-06-2019, 02:44 PM)mikesez Wrote:

(02-06-2019, 02:28 PM)jj82284 Wrote: That's not how it works.  Day one of the market you have to work at repaying all that r & d over time.  It's not a magic wand and the consumer pays for a.) The cost of bringing the drug to market and the additional cost of capital not being invested to create a competing drug.

You're either being dense or obfuscating.  Wrong_box knows how business works, and so do I.  Nothing he said was wrong.  It is reasonable for a new drug to be very expensive when it first enters the market.  There is no reason for that price to increase afterwards.  It should only ever go down until all of the initial investment, plus a reasonable margin, is paid off.  Then and only then there could be small price increases due to the cost of inputs, like labor, or botanicals, or petroleum, changing.  That is not what we see when we look at real drugs made by real companies.  We see unexplained and very high price increases even as everything else we can measure remains constant.  Again, look at Humalog insulin.

How much did it cost to bring that product to the market?

---